Valuation Update With 7 Day Price Move • May 12
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to ₩10,430, the stock trades at a trailing P/E ratio of 18.7x. Average trailing P/E is 19x in the Personal Products industry in South Korea. Total returns to shareholders of 41% over the past three years. Valuation Update With 7 Day Price Move • Apr 20
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩15,100, the stock trades at a forward P/E ratio of 14x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 98% over the past three years. Announcement • Apr 01
Green Cross Holdings Corporation (KOSE:A005250) acquired 22.08% stake in GREEN CROSS WellBeing Corporation (KOSDAQ:A234690) from GC Biopharma Corp. (KOSE:A006280) for KRW 50.5 billion. Green Cross Holdings Corporation (KOSE:A005250) acquired 22.08% stake in GREEN CROSS WellBeing Corporation (KOSDAQ:A234690) from GC Biopharma Corp. (KOSE:A006280) for KRW 50.5 billion on March 31, 2026. A cash consideration of KRW 50.45 billion will be paid by Green Cross Holdings Corporation. As part of consideration, KRW 50.45 billion is paid towards common equity of GREEN CROSS WellBeing Corporation. The transaction will be financed through bank borrowing of KRW 50.45 billion.
Green Cross Holdings Corporation (KOSE:A005250) completed the acquisition of 22.08% stake in GREEN CROSS WellBeing Corporation (KOSDAQ:A234690) from GC Biopharma Corp. (KOSE:A006280) on March 31, 2026. Valuation Update With 7 Day Price Move • Mar 23
Investor sentiment improves as stock rises 30% After last week's 30% share price gain to ₩11,800, the stock trades at a forward P/E ratio of 11x. Average forward P/E is 14x in the Personal Products industry in South Korea. Total returns to shareholders of 75% over the past three years. Reported Earnings • Mar 21
Full year 2025 earnings: EPS and revenues miss analyst expectations Full year 2025 results: EPS: ₩564 (up from ₩398 in FY 2024). Revenue: ₩164.7b (up 23% from FY 2024). Net income: ₩10.0b (up 42% from FY 2024). Profit margin: 6.1% (up from 5.3% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 3.2%. Earnings per share (EPS) also missed analyst estimates by 42%. Revenue is forecast to grow 17% p.a. on average during the next 2 years, compared to a 17% growth forecast for the Personal Products industry in South Korea. New Risk • Mar 21
New major risk - Financial position The company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 8.9% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (8.9% operating cash flow to total debt). Minor Risk Paying a dividend despite having no free cash flows. Valuation Update With 7 Day Price Move • Sep 09
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩10,400, the stock trades at a trailing P/E ratio of 22.1x. Average trailing P/E is 23x in the Personal Products industry in South Korea. Total returns to shareholders of 35% over the past three years. Valuation Update With 7 Day Price Move • May 02
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩9,400, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 15x in the Personal Products industry in South Korea. Total returns to shareholders of 6.1% over the past three years. New Risk • Mar 31
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩145.0b (US$98.5m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Market cap is less than US$100m (₩145.0b market cap, or US$98.5m). Announcement • Feb 14
GREEN CROSS WellBeing Corporation announced that it expects to receive KRW 20 billion in funding GREEN CROSS WellBeing Corporation announced a private placement to issue Zero Coupon Series 1Unregistered Unsecured Private Placement Convertible Bonds due February 14, 2030 for gross proceeds of KRW 20,000,000,000 on February 12, 2025. The transaction will include participation from new investor For Human Life Wellbeing No.1 PEF. The transaction has been approved by shareholders of company, restricted to a hold period, and expected to close on February 14, 2025, bears zero coupon rate, 3% coupon rate and maturity rate, matures on February 14, 2030, 100% convertible into 2,110,149 shares at a fixed conversion price of KRW 9,478 from February 14, 2026 to January 14, 2030. Announcement • Feb 11
GREEN CROSS WellBeing Corporation, Annual General Meeting, Mar 25, 2025 GREEN CROSS WellBeing Corporation, Annual General Meeting, Mar 25, 2025, at 09:30 Tokyo Standard Time. Location: conference room, 76, yeouinaru-ro, yeongdeungpo-gu, seoul South Korea Upcoming Dividend • Dec 20
Upcoming dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 27 December 2024. Payment date: 06 April 2025. Trailing yield: 1.0%. Lower than top quartile of South Korean dividend payers (3.9%). In line with average of industry peers (1.1%). Valuation Update With 7 Day Price Move • Dec 16
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₩9,920, the stock trades at a trailing P/E ratio of 26.3x. Average trailing P/E is 17x in the Personal Products industry in South Korea. Total returns to shareholders of 1.6% over the past three years. New Risk • Dec 02
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported March 2024 fiscal period end). Share price has been volatile over the past 3 months (9.5% average weekly change). Valuation Update With 7 Day Price Move • Nov 12
Investor sentiment deteriorates as stock falls 16% After last week's 16% share price decline to ₩9,170, the stock trades at a trailing P/E ratio of 24.3x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 10% over the past three years. Valuation Update With 7 Day Price Move • Sep 12
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₩9,880, the stock trades at a trailing P/E ratio of 26.2x. Average trailing P/E is 20x in the Personal Products industry in South Korea. Total loss to shareholders of 1.3% over the past three years. New Risk • Jul 17
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩134.6b (US$97.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Valuation Update With 7 Day Price Move • Feb 05
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to ₩8,300, the stock trades at a trailing P/E ratio of 20.8x. Average trailing P/E is 33x in the Personal Products industry in South Korea. Total loss to shareholders of 36% over the past three years. New Risk • Jan 30
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Jan 19
Investor sentiment improves as stock rises 28% After last week's 28% share price gain to ₩10,080, the stock trades at a trailing P/E ratio of 25.3x. Average trailing P/E is 32x in the Personal Products industry in South Korea. Total loss to shareholders of 27% over the past three years. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₩8,130, the stock trades at a trailing P/E ratio of 20.4x. Average trailing P/E is 31x in the Personal Products industry in South Korea. Total loss to shareholders of 40% over the past three years. Upcoming Dividend • Dec 20
Inaugural dividend of ₩100.00 per share Eligible shareholders must have bought the stock before 27 December 2023. Payment date: 08 April 2024. This is the first dividend for GREEN CROSS WellBeing since going public. The average dividend yield among industry peers is 1.2%. New Risk • Jun 23
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: ₩129.8b (US$99.1m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Upcoming Dividend • Dec 21
Inaugural dividend of ₩80.00 per share Eligible shareholders must have bought the stock before 28 December 2022. Payment date: 11 April 2023. This is the first dividend for GREEN CROSS WellBeing since going public. The average dividend yield among industry peers is 1.3%. Valuation Update With 7 Day Price Move • Dec 07
Investor sentiment improved over the past week After last week's 16% share price gain to ₩7,490, the stock trades at a trailing P/E ratio of 18.8x. Average trailing P/E is 21x in the Personal Products industry in South Korea. Total loss to shareholders of 18% over the past three years. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment deteriorated over the past week After last week's 16% share price decline to ₩7,490, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 15x in the Personal Products industry in South Korea. Total loss to shareholders of 35% over the past year. Upcoming Dividend • Dec 22
Inaugural dividend of ₩50.00 per share Eligible shareholders must have bought the stock before 29 December 2021. Payment date: 07 April 2022. The company is not currently making a profit and is not cash flow positive. This is the first dividend for GREEN CROSS WellBeing since going public. The average dividend yield among industry peers is 0.8%. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment improved over the past week After last week's 35% share price gain to ₩12,550, the stock trades at a trailing P/E ratio of 79.5x. Average trailing P/E is 25x in the Personal Products industry in South Korea. Total loss to shareholders of 9.4% over the past year. Announcement • Feb 10
GREEN CROSS WellBeing Corporation, Annual General Meeting, Mar 24, 2021 GREEN CROSS WellBeing Corporation, Annual General Meeting, Mar 24, 2021, at 09:00 Korea Standard Time. Upcoming Dividend • Dec 22
First Dividend Is ₩80.00 Per Share Will be paid on the 7th of April to those who are registered shareholders by the 29th of December. This is the first dividend for GREEN CROSS WellBeing since going public. The average dividend yield among industry peers is 0.6%. 
